ODAN-SODIUM POLYSTYRENE SULFONATE

Google image searchProduct monograph

Active ingredient

sodium polystyrene sulfonate, 1 G/G

DIN: 02473941

Dosage form(s): POWDER FOR SUSPENSION

Route(s) of administration: ORAL, RECTAL

Schedule: Prescription

Company: ODAN LABORATORIES LTD

Date: 25-OCT-2018

ATC:

• V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
• V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
• V03AE — Drugs for treatment of hyperkalemia and hyperphosphatemia (ATC, ATC/DDD)
• V03AE01 — POLYSTYRENE SULPHONATE (ATC/DDD)

Reference brand drug: Kayexalate

Pharmaceutical standard: USP

External Links for Odan-Sodium Polystyrene Sulfonate

Search on Google

• Odan-Sodium Polystyrene Sulfonate side effects
• Odan-Sodium Polystyrene Sulfonate dosage
• sodium polystyrene sulfonate side effects
• sodium polystyrene sulfonate dosage

Odan Laboratories Ltd

Go to Odan Laboratories website to see drug product details. Sometimes you can find odan-sodium polystyrene sulfonate photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.